Literature DB >> 1318759

Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.

S Valentin, P Ostergaard, H Kristensen, O Nordfang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1318759

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN： 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  4 in total

1.  Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.

Authors:  You fu Li; Frederick A Spencer; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 2.  Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease.

Authors:  Susan M Cheer; Christopher J Dunn; Rachel Foster
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.

Authors:  H A Friedel; J A Balfour
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

4.  TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.

Authors:  Benedicte Stavik; Mari Tinholt; Marit Sletten; Grethe Skretting; Per Morten Sandset; Nina Iversen
Journal:  J Hematol Oncol       Date:  2013-01-15       Impact factor: 17.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.